- News
- Events
- Careers
- Services
- Our services
- Drug Substance Process development, analytical development, analysis, stability testing, manufacturing
- Solid State Research Crystal structure by X-ray, solid form screening, solid form selection, IP support
- Drug Product Formulation development, analytical development, manufacturing, stability studies
- Clinical Supply Packaging, labeling, clinical trial logistics
- Bioanalysis Mass spectrometry, immunochemistry, flow cytometry, in-vitro drug discovery, clinical trial services
- CMC Regulatory Support Scientific report writing, module 3 writing, regulatory CMC support
- Advanced solutions
- Nanomedicines Guiding your nanomedicine candidate through its journey to the clinic
- Bioavailability Enhancement Developing and manufacturing formulations that lead to improved bioavailability
- Oral Drugs Bringing your oral drug to clinical trials quickly and reliably
- Injectable Drugs Guiding you through the development of injectable drug products to GMP standards
- Preparative HPLC Purification Enhancing biomolecule purity with tailored solutions for GMP-grade materials at scale
- Our services
- Integrated Platforms
-
Our integrated platforms
Program management
Using the right standards at the right development phase, our comprehensive program management services streamline your small molecule drug development.
Drug substance
Helping you turn your compounds that show promise into GMP-grade drug substances.
- Process development
- Analytical development
- Solid State Research
- API manufacturing
Drug product
We advance your clinical candidates through the pipeline quickly and safely with specialist drug product services.
- Formulation
- Analytical methods
- GMP manufacturing
- Clinical Supply
Bioanalysis
Our bioanalytical platform supports your preclinical and clinical stages with expert testing services.
- Mass spectrometry
- Immunochemistry
- Flow cytometry
- qPCR
CMC regulatory services
Our comprehensive CMC regulatory services streamline preparation and submission of your registration file.
See AlsoChristian Wolff and the German EnlightenmentMan dead after tornado touches down near Montreal | CBC NewsWolff: Verstappen could still leave Red BullMax Verstappen: Christian Horner tells Toto Wolff to focus on Mercedes' form and not 'unavailable' drivers- Scientific report writing
- Module 3 writing
- Regulatory CMC support
Program management
Using the right standards at the right development phase, our comprehensive program management services streamline your large molecule drug development.
Drug product
We advance your large molecule candidates through the pipeline quickly and safely with specialist drug product services.
- Formulation
- Analytical methods
- Aseptic manufacturing
- Clinical Supply
Bioanalysis
Our bioanalytical platform supports your large molecule drugs through preclinical and clinical stages with expert testing services.
- Mass spectrometry
- Immunochemistry
- Flow cytometry
- qPCR
CMC regulatory services
Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your large molecule drug.
- Scientific report writing
- Module 3 writing
- Regulatory CMC support
Program management
Using the right standards at the right development phase, our comprehensive program management services streamline your nanomedicine drug development.
Drug product
We turn your nanomedicine candidates into suitable drugs with specialist development and manufacturing services.
- Building block synthesis
- Process development
- GMP production
- Analytical development
Bioanalysis
Our bioanalytical platform supports your preclinical and clinical stages with expert testing services.
- Mass spectrometry
- Immunochemistry
- Flow cytometry
- qPCR
CMC regulatory services
Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your nanomedicines.
- Scientific report writing
- Module 3 writing
- Regulatory CMC support
-
- Resources
- About us
- About us
- Mission and Vision Always agile, we reliably guide you and your molecule through the challenging terrain of early phase development
- Facilities Carefully engineered to support and enable early phase development for our partners’ oral drugs, injectables and nanomedicines
- Leadership team Our leadership team has a deep scientific understanding combined with exceptional experience
- History Platforms and facilities that are uniquely engineered to support and enable integrated early phase development
- Working at Ardena We’re a fast-growing EU-based company with many opportunities for you to grow and progress with us
- About us
- Contact
- Services
- Our services
- Drug Substance
- Solid State Research
- Drug Product
- Clinical Supply
- Bioanalysis
- CMC Regulatory Support
- Advanced solutions
- Nanomedicines
- Bioavailability Enhancement
- Oral Drugs
- Injectable Drugs
- Program Management
- Our services
- Resources
- About Us
- Mission and Vision
- Facilities
- Leadership team
- History
- Working at Ardena
- Contact
Home About us Leadership team
Our leadership team has a deep understanding and exceptional experience in their respective fields of expertise which we leverage to guide our approach and deliver the best possible outcomes for our partners.
CEO
Harry Christiaens, PhD
Harry has significant leadership experience with 15+ years in the pharma and biotech industry. He successfully transformed Pharmavize, a regulatory consultancy company into a leading CDMO, establishing a GMP team and infrastructure from scratch. Since 2015, he led the acquisitions and integration of five companies providing highly complimentary services. He successfully integrated the service offering of the acquired companies onto one platform, creating the Ardena brand.
Harry Christiaens, PhD
COO
Gerjan Kemperman, PhD
Gerjan has significant leadership experience with 15+ years in the pharma industry. He worked previously at Organon/MSD in various leadership roles. Gerjan co-founded ChemConnection in 2012. He successfully led and grew the company and finally managed its buyout to Mentha Capital in 2018.
Gerjan Kemperman, PhD
CFO
Filip Van Herck, CPA
Filip assumed the role of Chief Financial Officer at Ardena in October 2017. Prior to his appointment, he held various positions at Capsugel (following its spin-out from Pfizer) and Lonza (after its acquisition of Capsugel). He was responsible for overseeing the coordination of IPO readiness efforts and the integration of finance departments following the Lonza-Capsugel acquisition. …
Read full bio
Filip Van Herck, CPA
Filip assumed the role of Chief Financial Officer at Ardena in October 2017. Prior to his appointment, he held various positions at Capsugel (following its spin-out from Pfizer) and Lonza (after its acquisition of Capsugel). He was responsible for overseeing the coordination of IPO readiness efforts and the integration of finance departments following the Lonza-Capsugel acquisition. Earlier in his career, Filip worked at Cisco, where he held several financial positions of increasing responsibility. He obtained a degree in Applied Economics from the University of Leuven in Belgium, and a degree in Business Studies from the Michael Smurfit Business School in Ireland. Filip is a Certified Public Accountant (AICPA).
Corporate Business Development Director
Guido Wallraff
Guido is an entrepreneurial-minded senior executive with consistent successes in starting, building, growing and improving revenue and profitability of life science product and service businesses. Guido has more than 25 years of experience.
Guido Wallraff
Your molecule, your journey, our mission.
Get in touch to see how we can craft your path to the clinic with dedicated capabilities.
Get in touch
